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SERVITIZATION AND CO-OPETITION IN THE PHARMACEUTICAL INDUSTRY 
 
 




Purpose: The present paper aims at providing an outlook of the portfolio of services developed by 
the pharmaceutical distribution in Spain and Portugal by looking at the different types and levels of 
implementation. This paper also provides the research framework that is currently the base for the 
ongoing data collection, exploring the rationale behind the implementation of different types of 
services and co-opetitive relationships in relation to the pursuit of profit, the creation of barriers with 
competitors and the reinforcement of customer loyalty. The impact of these factors on the intention 
to increase the delivery of services in the future will also be analysed. 
Design/methodology/approach: In order to address the research framework presented, a 
quantitative research methodology is suggested through the use of web-based questionnaires. After 
the identification and categorization of services in this industry, a questionnaire was developed in 
order to measure the presence of the identified services and their impact on the pursuit of profit, the 
creation of competitive advantages the improvement of customer loyalty, willingness to further 
develop these services and co-opetitive relationships. The sample includes Portuguese and Spanish 
pharmaceutical cooperatives and private companies, operating as wholesalers. 
Findings: The empirical data is currently being collected therefore the present paper provides solely 
the analysis of the pharmaceutical industry in both countries and the classification of the services 
offered in this industry which was used as the basis to develop the questionnaire.The paper discusses 
how the pharmaceutical distribution sector has evolved in the past decades and how the 
concentration process has changed the rules of the market owned by big players who are taking the 
lead. Additionally, the portfolio of new services that have recently been developed throughout the 
industry are identified. Some differences between both countries have been found mainly in IT 
services. The recent establishment of second degree cooperatives generates new perspectives to the 
suggested influence of co-opetitive relationships. 
Originality/value: The present paper is part of an ongoing research project which aims at providing 
both theoretical and practical implications:  
1) The analysis of pharmaceutical wholesalers from a servitization perspective; 
2) Application of Baines et al. (2013) classification to the pharmaceutical sector; 
3) The adaptation and measurement of co-opetitive relationships within the servitization 
delivery; 
4) Development of instruments to measure the level of implementation and the type of 
services which can be used in the future to make compared studies in other countries; 
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1. INTRODUCTION 
In the majority of developed countries, the service sector has become key to competitiveness, 
strongly contributing towards economic growth. This inclination towards services is also reflected in 
the industrial sector that exhibits organic growth through the development of new services. Still, the 
provision of added/additional services remains a major challenge for manufacturing firms, 
particularly if they have strongly engrained traditional business models (Brax, 2005). 
 
Services have been defined as activities or performance provided to satisfy customer needs 
(Grönroos, 1990). Nonetheless, in an increasingly competitive market, customers expect more and 
whatever was before an order-winner quickly becomes a qualifier affecting the whole industry (for 
example the case of quality - Lee, Zuckweiler and Trimi, 2006).  
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Companies have adapted to these demands for added value and increased their product-service 
offerings, combining products and services to such a degree that it is almost impossible to separate 
them and clearly distinguish them. Complete bundles and packages - referred to as product-service 
systems (PSS) - are developed and they are so intertwined that customers struggle to distinguish 
between what is the product and what is the added service (Aurich et al., 2009; Schmenner, 2009). 
This is particularly the case for the pharmaceutical industry which had to find new ways to compete 
in a highly regulated market with static margins. Hence the focus of this paper on the servitization 
levels of implementation offered by Portuguese and Spanish pharmaceutical distributors. 
Additionally, strategical reasons for this implementation are analysed as well as the intention to 
develop the different types of services identified. 
 
In addition to this, emphasis has also been placed in “service‐driven global supply chains” (Youngdahl 
and Loomba, 2000) and the role of customer relationship management and “service relationships” 
(Rust and Chung, 2006) as well as the role of intra and inter-firm relationships management (Mena, 
Humphries and Wilding, 2009; Soares, Soltani and Liao, 2012). Following the trends identified in the 
review of the servitization literature (Baines et al., 2009; Lightfoot et al. 2013) this study focuses on 
servitization as a means to create added value to traditional offerings by developing new capabilities. 
This paper focuses particularly on servitization as an instrument to simultaneously create long term 
relationships with customers and entry barriers to competitors. By providing a combination of 
enhanced features to their customers, companies try to go beyond the core services strictly expected 
from them and establish stronger bonds with their customers, increasing switching costs and making 
it harder for competitors to reclaim competitive advantage.  
 
An empirical methodology is suggested to achieve this, building upon a conceptual research 
framework. As part of ongoing data collection, this paper offers a descriptive analysis of the sector as 
well as a classification of the available services. Subsequently, the present paper is structured into 
five main sections: 1) Section 1 provided an Introduction of the research; 2) Section 2 provides a brief 
summary of the literature on servitization and co-opetition, suggesting a research framework for 
further empirical research; 3) following this, in Section 3 methodological aspects are discussed; 4) in 
Section 4, main findings for the Portuguese and Spanish industry are presented, providing a 
categorization of levels of services delivered in the pharmaceutical sector; 5) and finally Section 5 
offers concluding remarks. 
 
2. LITERATURE REVIEW 
 
2.1. Servitization 
First suggested by Vandermerwe and Rada (1988), the term servitization is used to refer to the 
competitive advantage created through the “process of creating value by adding services to 
products” (Baines, et al., 2009:547). Vendrell-Herrero, Bustinza and Arias (2014) affirm that 
servitization has been described as the provision of service as a complement to manufacturing and 
also commercialization of products generating higher economic margins. According to Gaspar and 
Bustinza (2014:225), servitization is related to the added services to a product whilst product-service 
systems (PSS) refer to the use of these services focusing on specific joint offerings. This is 
corroborated by Baines et al. (2013:638) which state that “servitization is the process of transforming 
manufacturers to compete through product-service systems (PSSs) rather than products alone”. In an 
attempt to categorize services, Martinez et al. (2010) distinguish product-service offerings from 
peripheral up to the development of close relationship between buyers and suppliers. In turn, going 
beyond production competences, Baines et al., (2013) suggest a categorisation of services that 
includes base, intermediate and advanced levels of services. The main difference between 
intermediate and advanced service levels is that in the first the supplier does not get fully involved in 
the customer business whilst in the second he does. In intermediate services, the supplier can offer 
more or less complex services, but only when those services are formally requested by the customer 
and with the supplier not knowing in detail what is the true nature of the customer business. 
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Whereas, in advanced services, the supplier perfectly understands the nature of the customer 
business and some of the customer’s business processes are embedded in the services offering. 
 
In their review of the servitization literature, Baines et al. (2009:558) refer that the majority of 
findings comes from case studies and summarize the main reasons that lead organisations towards 
the implementation of servitization. These include ﬁnancial (e.g. revenue stream and proﬁt margin), 
strategic (e.g. competitive opportunities and advantage) and marketing drivers (e.g. customer 
relationships and product differentiation). In doing so, they identify that the motivations behind this 
approach and resulting benefits clearly go beyond profitability. By adding services to their product 
offerings, companies are able to set themselves apart from their competitors, developing sustainable 
and hard to copy advantages (Oliva and Kallenberg, 2003; Gebauer et al., 2006; Kowalkoski and 
Kindström, 2013). As such, this generates repeated purchases and customer loyalty (Correa et al., 
2007). Creating this privileged relationship with buyers facilitates the promotion of further services 
and products which in turn contributes towards the increase of entry barriers and switching costs 
(Mathieu, 2001b). Brax (2005) has identified six main challenges in the development of product-
service combinations related to product design, production, delivery, marketing, communication and 
relationship with clients. Consequently, the present research considers the impact of relationship 
management as suggested next. 
 
2.2. Co-opetitive relationships 
In the same way that it is not possible to discuss manufacturing without referring to supply chain 
coordination, it is not possible to discuss servitization without considering the relationships 
established within and between companies to provide these added value product offerings. This is 
particularly the case in the pharmaceutical industry, the focus of this research, in which wholesalers 
are organised under the form of cooperatives and private companies jointly serving the same 
market. As a result, these companies are forced to simultaneously compete and collaborate in order 
to satisfy their customers’ needs. This is what is commonly referred to in manufacturing and 
operational research as co-opetitive relationships. The term ‘co-opetition’, first defined by Ray 
Noorda, CEO of Novell (1993; cited by Nalebuff and Brandenburger, 2002:4), has been used in the 
literature to refer to situations in which two competing suppliers (of a given buyer, for example 
Toyota) cooperate towards the achievement of common buyer goals (Wu, Choi and 
Rungtusanatham, 2010). Nonetheless, research as shown that co-opetitive relationships can occur 
within and between firms (Schiavone and Simoni, 2011). Hence, these relationships can be loosely 
defined as situations in which companies simultaneously compete for orders and cooperate for self-
preservation towards the achievement of supply chain goals (Choi et al., 2002; Choi, 2007; Nalebuff 
and Brandenburger, 2002; Wu, Choi and Rungtusanatham, 2010). 
 
2.3. Research Framework 
Servitization and product-service systems (PSS) came to the forefront of research interests propelled 
by authors such as Brax (2005), Neely (2008), Baines et al. (2009, 2013a,b) reviews of the literature, 
studies and breakthroughs, calling for much needed further research in the field. In an attempt to 
contribute to this literature, this paper focuses on the implementation of servitization in the 
pharmaceutical industry. Building upon Baines et al. (2013) categorization of services (into Base, 
Intermediate and Advanced services) this research aims at comparing the levels and types of services 
implemented in the Portuguese and Spanish pharmaceutical distributors. In doing so, the suggested 
empirical research attempts to address the following research questions: RQ1. How is servitization 
applied in the pharmaceutical industry?; RQ2. How has the industry evolved in the last years in Spain 
and Portugal? To what extent has the economic crisis impacted on pharmaceutical distribution?; 
RQ3. What types of service categories are present in the pharmaceutical distribution of both 
countries and to what extent?; RQ4. How can the identified services be categorised against the three 
levels of service (Baines, 2013); RQ5. What is the impact of the different level of services in these 
three strategic factors: loyalty, creation of competitive advantages and profitability?; RQ6. What is 
the influence of loyalty, creation of competitive advantages and profitability in the willingness to 
increase the level of service implementation in the future?; RQ7. Is there any association between 
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the establishment of co-opetitive relationships and the implementation of different types of services, 
strategic factors and willingness to increase the service in the future? Figure 1 depicts the research 




Figure 1: Servitization and co-opetition research framework. 
 
3. METHODOLOGY 
As a means to answer the research questions and investigate the research framework proposed, an 
empirical web-based survey research is suggested. The survey addresses all the elements of the 
framework and was developed based on the categorization of services in the pharmaceutical 
industry provided in this document. Hence, for the purpose of this conference paper, a descriptive 
analysis of the sector is provided as well as a classification of the available services. For the currently 
undergoing data collection, several statistical analyses will be performed including contingency 
tables, comparison of means, association measures and multiple regression. Independent variables 
such as the type of company (cooperative or private), amongst other control variables will also be 
used to compare groups. 
 
4. THE PHARMACEUTICAL DISTRIBUTION IN SPAIN AND PORTUGAL 
The pharmaceutical distribution sector in Spain commenced its development between the 1930 and 
the 1960s, when 24 new distributors were founded. The majority of them were incorporated under 
the cooperative form integrated by pharmacy owners in specific regions. By the end of the last 
century, 32 out of the 41 players were still cooperatives while the rest were private companies. 
Although with some marginal corporate operations in the 80s and 90s, it has been during the new 
century that numerous corporate movements have occurred, including not only mergers and 
acquisitions but also different cooperative integrations and federations. All these corporate changes 
had a significant impact on the market split. In 1995 the top 8 companies had just over 50% of the 
market share what implies a fairly fragmented marketed, whereas in 2013 they increased to almost 
90%. Figures 2 a) and 
b) below illustrate these market share changes. 
 
Conversely, the pharmaceutical distribution sector in Portugal did not start to flourish until the 
1960s-1990s when more than 20 distribution companies were founded. From those 20 newcomers, 5 
were cooperatives and the rest were private companies. As opposed to what occurred in Spain, the 
consolidation process commenced in 1985 and intensified in the early nineties with various 
takeovers by both private companies and cooperatives. Due to that early process of consolidation, 
the market was relatively concentrated by 2003 already when the top 7 wholesalers had close to 85%  
of the market share. That decrease in the market fragmentation has continued and in 2013 the seven 
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Figure 2: Changing market shares in the Spanish market 











Figure 3: Changing market shares in the Spanish market 
(p) Private company / (c) Cooperative / (cf) Cooperative federation 
 
Although there are some similarities in both countries that certainly invite to prepare a common 
analysis of the pharmaceutical distribution sector, there are three differences that deserve to be 
highlighted: (1) The latter development towards a modern configuration of the Portuguese industry 
vs. the Spanish one; (2) The balanced presence of both private companies and cooperatives in 
Portugal compared to Spain, where the importance of cooperatives is notably higher; (3) The even 
higher level of concentration experimented in the Portuguese market due to an earlier period of 
consolidation. 
 
Nevertheless, it is also reasonable to believe that in both markets, Spain and Portugal, there are two 
key and common reasons behind the consolidation process described before. Firstly, the direct 
impact of new legislations introduced as a result of the reductions of public budget dedicated to 
medication. 
 
This in turn affected sales prices and contribution margins defined for wholesalers. Secondly, the 
reduction of public health spending also resulted in additional strains for pharmacies in terms of 
delays in reimbursements from the government, which indirectly impacted to wholesalers as billing 
periods and stocks increased. Thus, consolidation of the industries was the natural response to the 
new circumstances. An evolution aimed to not only look for economies of scales and cost reductions 
but also to enhance the portfolio of services that can be offered to the pharmacies, which led to the 
servitization process of this sector that is here under analysis. Another important factor that has 
contributed to the servitization process is that, in both countries, the commercial margin of 
pharmaceutical distributors is regulated and fixed by the administration (Frías 2001). Since they 
cannot increase their margins they have to grow through other strategies and the most used has 
been the development of new services. 
A preliminary analysis of the services portfolio of the most relevant Spanish and Portuguese 
wholesalers has resulted in five different groups of services depending on their content and/or area 
b) Market shares in Portugal in 2013 (Compilation 
based on data from Alliance Healthcare, 2014) 
 
a) Market shares in Portugal in 2003 (Compilation 
based on data from Rodrigues et al., 2005) 
a) Market shares in Spain in 1995 (Compilation based on 
data from IMS, 1996 cited by Frías Jamilena, 2001). 
b) Market shares in Spain in 2013 (Compilation 
based on data from IMS cited by FEDIFAR, 2014). 
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of focus. Although the majority of services identified have been found in both markets – Spain and 
Portugal – the level of implementation is remarkably different. In Portugal only 7 out of the 26 
identified services are offered on average compared to 14 services in Spanish companies. For 
example, whereas Portuguese companies have shown a limited introduction of services related to IT 
(which is offered apparently by only one out of the seven leading companies), Spanish companies 
seem to be one step ahead in this area, especially cooperatives which very often include some kind 
of IT services in their portfolio. Nevertheless, the extent of implementation of these services will be 
tested in the empirical part of this research. 
 
4.1. Classification of service levels 
Adopting Baines et al (2013) service levels categorisation, the three levels of services in the 
pharmaceutical distribution industry have been defined as follows: a) Base Services: refer to the 
distribution itself. In this case, the customer only values the supply of products that basically 
comprises the logistics of storage and delivery. There is not much value- added proposition and 
therefore few differentiation between companies is possible; b) Intermediate Services: added 
services that tend to add-up to the delivery of base services. These improvements are in a related 
field to the base service already provided such as the supply of complement products/services in the 
pharmaceutical industry. That means that all the tools and services provided to improve the supply 
chain in terms of time, accuracy or cost should be considered as Intermediate Services. That includes, 
for example, IT services (installation and running of specific software) aimed to manage stocks, 
orders and more frequent delivery services; c) Advanced Services: the outcome of these services 
goes beyond and is not limited to something related to the Base Service. The service offered creates 
enhanced value, that is, it engages “the customer in a relationship that has closer association with 
strategic repositioning and business process outsourcing than to sales of products and services” 
(Baines and Lightfoot, 2013:65). The portfolio of services identified in the pharmaceutical industry 
includes five Categories as detailed in Table 1. 
 
Services group Description Service Level Services included 
1. Core services Services related to the core 
activity of sale and 
distribution (storage and 
delivery) 
Base Services related to the core activity of sale 
and distribution: Other health products 
distribution; Other not health products 
distribution; Special and urgent deliveries; 
Vaccines services; Dispose of medicines; 
Laboratories returns. 
2. IT services Sales, installation, 
maintenance and training of 
IT systems 
Intermediate Services aimed to introduce the utilization 
of IT systems: ERP software; Software 
maintenance; Hardware maintenance; 





advisory, HR, etc. 
Advanced Other professional services: Administrative 
and accountancy; Management advice; HR 
and recruiting; Marketing and 
communication; Loyalty programs. 
4. Training and 
dissemination 
Training about different 
contents and publications 
(magazines, technical notes, 
etc.) 
Intermediate Training and dissemination services: 
Management training; Technical training; 
Social networks and internet; Magazines; 
Other publications. 
5. Third parties 
services 
Agreements with third 
parties to incorporate their 
services in the wholesaler 
offering 
Advanced Services provided by third parties: Financial 
services; Renovation and decoration; 
Occupational risk prevention; Data 
protection; Private label manufacturing. 
  
Table 1: Levels of services groups 
 
5. CONCLUSIONS 
The pharmaceutical sector has a crucial economic and social impact, playing an essential role in the 
provision of medical and health care, particularly due to the R&D investments required for the 
development of new medication (Frías, 2001). As such, and because the European regulations are 
129
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still lagging behind in terms of industry standardisation, it is imperative that we understand how the 
pharmaceutical industry currently operates and more importantly how servitization is approached in 
such a competitive market. The present paper outlined a framework that suggests co-opetition, 
strategic factors and willingness towards development as key variables for the pharmaceutical 
industry. Key categories of services provided in the pharmaceutical industries were also identified 
based on a sample of Portuguese and Spanish wholesalers. Further consideration and categorization 
of each of the five categories in each of the 3 levels of service needs to be developed. Future 
research should consider whether or not all the services included in a group of services are 
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